January 28, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(3)
Amendment no. 1 to pricing supplement dated December 30, 2025 to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 5-III dated
March 5, 2025, the prospectus and prospectus supplement, each dated April 13, 2023,
and the prospectus addendum dated June 3, 2024
JPMorgan Chase Financial Company LLC
Structured Investments
Auto Callable Contingent Interest Notes Linked to the MerQube US
Large-Cap Vol Advantage Index due January 3, 2031
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
Notwithstanding anything to the contrary set forth in the pricing supplement dated December 30, 2025, related to the notes referred to
above (the "pricing supplement"), the Original Issue Date (Settlement Date) and pertinent provision are set forth as follows:
• The notes priced on December 30, 2025 and settled on January 5, 2026.
Original Issue Date (Settlement Date): January 5, 2026
CUSIP: 48136MMU8
Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying
prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the
accompanying product supplement, "Risk Factors" beginning on page US-4 of the accompanying underlying supplement and
"Selected Risk Considerations" beginning on page PS-7 of the pricing supplement.
Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this amendment, the pricing supplement or the accompanying product
supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the
contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement and the related product supplement, underlying supplement,
prospectus supplement and prospectus and prospectus addendum, each of which can be accessed via the hyperlinks below. Please
also see "Additional Terms Specific to the Notes" in the pricing supplement.
• Pricing supplement dated December 30, 2025:
• Product supplement no. 4-I dated April 13, 2023:
• Underlying supplement no. 5-III dated March 5, 2025:
• Prospectus supplement and prospectus, each dated April 13, 2023:
• Prospectus addendum dated June 3, 2024: